“…To the authors' knowledge, there have been only 2 brief reports of dabigatran complications in the medical literature on cutaneous surgery 18,19 and no published data on rivaroxaban. In this study, the authors found that no patients taking dabigatran or rivaroxaban experienced severe or life-threatening hemorrhagic complications from cutaneous surgery.…”
Section: Discussionmentioning
confidence: 99%
“…13 Complications with dabigatran during cutaneous surgery have been discussed, with 1 report of an elderly patient on dabigatran in whom a subarachnoid hemorrhage developed during dermabrasion for scar revision. 19 However, it could not be determined whether the events were related. Another article briefly mentioned a patient on dabigatran in whom a hematoma developed after melanoma excision.…”
mentioning
confidence: 99%
“…Another article briefly mentioned a patient on dabigatran in whom a hematoma developed after melanoma excision. 18 Currently, the published data on cutaneous surgery complications associated with these new oral anticoagulants are limited to 2 brief references on dabigatran 18,19 and none on rivaroxaban. With the continued advent of new blood-thinning medications, perioperative management of patients during cutaneous surgery will become even more complex.…”
Because no patients on dabigatran or rivaroxaban experienced severe hemorrhagic complications during cutaneous surgery, a strategy of continuing these medically necessary medications during cutaneous surgery seems reasonable.
“…To the authors' knowledge, there have been only 2 brief reports of dabigatran complications in the medical literature on cutaneous surgery 18,19 and no published data on rivaroxaban. In this study, the authors found that no patients taking dabigatran or rivaroxaban experienced severe or life-threatening hemorrhagic complications from cutaneous surgery.…”
Section: Discussionmentioning
confidence: 99%
“…13 Complications with dabigatran during cutaneous surgery have been discussed, with 1 report of an elderly patient on dabigatran in whom a subarachnoid hemorrhage developed during dermabrasion for scar revision. 19 However, it could not be determined whether the events were related. Another article briefly mentioned a patient on dabigatran in whom a hematoma developed after melanoma excision.…”
mentioning
confidence: 99%
“…Another article briefly mentioned a patient on dabigatran in whom a hematoma developed after melanoma excision. 18 Currently, the published data on cutaneous surgery complications associated with these new oral anticoagulants are limited to 2 brief references on dabigatran 18,19 and none on rivaroxaban. With the continued advent of new blood-thinning medications, perioperative management of patients during cutaneous surgery will become even more complex.…”
Because no patients on dabigatran or rivaroxaban experienced severe hemorrhagic complications during cutaneous surgery, a strategy of continuing these medically necessary medications during cutaneous surgery seems reasonable.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.